Our Sites » TechNews TechDatabase Canadian Private Equity Register     Login

Home » M&As, VC/PE News » VCs Sell Aegera Therapeutics, Likely at Loss

VCs Sell Aegera Therapeutics, Likely at Loss

Pharmascience, a generic pharmaceutical company, announced today that it has acquired Aegera Therapeutics Inc., a Montreal based clinical-stage biotechnology company focused on developing targeted therapeutics to address... 

To Read This Article, please Login





See Also:

Copyright © 2013 TechFinance.ca. All rights reserved. | Healthy Living | wp-tips.
More in M&As, VC/PE News (416 of 616 articles)


...